Talis Biomedical's total assets for Q2 2024 were $72.70M, a decrease of -11.87% from the previous quarter. TLIS total liabilities were $24.07M for the fiscal quarter, a -6.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.